Skip to main content
logo
DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
9.36
+0.32 (3.54%)
At close: Nov 6, 2026, 4:00 PM EST
9.52
+0.16 (1.71%)
After-hours: Nov 6, 2026, 4:22 PM EST

DiaMedica Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
5054152321084299
Market Cap Growth
46.86%78.53%115.41%157.97%-57.63%-48.10%
Enterprise Value
46135918252651
Last Close Price
9.367.965.432.841.583.73

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
13.177.395.702.111.312.24
P/TBV Ratio
13.177.395.702.111.312.24

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.000.010.010.020.00
Net Debt / Equity Ratio
-1.13-1.06-1.08-1.03-1.04-1.02
Net Debt / EBITDA Ratio
1.111.741.642.472.363.31
Net Debt / FCF Ratio
1.372.051.982.802.853.67
Quick Ratio
6.6411.728.2319.1215.4929.69
Current Ratio
6.7211.818.2819.2715.6129.82
Return on Equity (ROE)
-114.61%-67.68%-53.27%-46.77%-36.06%-38.81%
Return on Assets (ROA)
-64.12%-39.92%-33.18%-30.02%-21.89%-23.16%
Return on Capital Employed (ROCE)
-102.10%-61.20%-65.10%-41.40%-43.40%-31.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-7.65%-7.90%-10.53%-17.98%-32.73%-13.78%
FCF Yield
-6.25%-7.02%-9.52%-17.40%-27.74%-12.45%
Buyback Yield / Dilution
-22.41%-16.28%-24.07%-23.16%-27.29%-32.48%
SEC Filings: 10-K · 10-Q